pectins and Peritonitis

pectins has been researched along with Peritonitis* in 6 studies

Trials

1 trial(s) available for pectins and Peritonitis

ArticleYear
[Enterosorption with pectin-containing medication in the treatment of peritonitis].
    Khirurgiia, 2005, Issue:4

    One hundred and fifty patients aged 19 to 86 years with general peritonitis mainly in a toxic (85.3%) stage were examined. The leading causes of peritonitis were acute appendicitis (24.0%) and perforation of gastroduodenal ulcers (21.3%). Three groups of patients were formed with a pair samples method for a comparative analysis of treatment. The control group of patients was treated conventionally. Entero-sorption was performed through naso-intestinal tube with well-known carbonic sorbent UAO-A and pectin-containing medication made of red beet. The results were compared. A 1.3-fold decrease in entero-paresis naso-intestinal intubation duration, a relief in severity of the patients' condition by SAPS scale as early as on day 2, improvement of immunity indices, faster reduction of toxicity of blood plasma and leukocytic index of intoxication, a 12% decrease in postoperative pneumonia morbidity and postoperative lethality from 14 to 6.6% demonstrated advantages of entero-sorption with pectin-containing medication.

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Appendicitis; Enterosorption; Follow-Up Studies; Humans; Middle Aged; Pectins; Peptic Ulcer Perforation; Peritonitis; Postoperative Complications; Time Factors

2005

Other Studies

5 other study(ies) available for pectins and Peritonitis

ArticleYear
Attenuation of Doxorubicin-Induced Small Intestinal Mucositis by Pectins is Dependent on Pectin's Methyl-Ester Number and Distribution.
    Molecular nutrition & food research, 2021, Volume: 65, Issue:18

    Intestinal mucositis is a common side effect of the chemotherapeutic agent doxorubicin, which is characterized by severe Toll-like receptor (TLR) 2-mediated inflammation. The dietary fiber pectin is shown to prevent this intestinal inflammation through direct inhibition of TLR2 in a microbiota-independent manner. Recent in vitro studies show that inhibition of TLR2 is determined by the number and distribution of methyl-esters of pectins. Therefore, it is hypothesized that the degree of methyl-esterification (DM) and the degree of blockiness (DB) of pectins determine attenuating efficacy on doxorubicin-induced intestinal mucositis.. Four structurally different pectins that differed in DM and DB are tested on inhibitory effects on murine TLR2 in vitro, and on doxorubicin-induced intestinal mucositis in mice. These data demonstrate that low DM pectins or intermediate DM pectins with high DB have the strongest inhibitory impact on murine TLR2-1 and the strongest attenuating effect on TLR2-induced apoptosis and peritonitis. Intermediate DM pectin with a low DB is, however, also effective in preventing the induction of doxorubicin-induced intestinal damage.. These pectin structures with stronger TLR2-inhibiting properties may prevent the development of doxorubicin-induced intestinal damage in patients undergoing chemotherapeutic treatment with doxorubicin.

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Doxorubicin; Esterification; Female; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Mice, Inbred C57BL; Mucositis; Pectins; Peritonitis; Structure-Activity Relationship; Toll-Like Receptor 2

2021
[Combined pectin containing drugs in the treatment of intestinal insufficiency syndrome].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2012, Issue:2

    Effectiveness employment of reseach pectin containing drug for enterosoption cause content pectin substances (5-7%), and protein-carbonic complex-balanced and presence such a important immunecorrects, as arginin and glutamic asid, probiotic of metabiotic type establish nutritive support in enteric insufficiency syndrome treatment. There was marked a beneficial effect during using pectin containing drug in the postoperative treatment of intestinal insufficiency, as was confirmed by evaluation of biopsy specimens of gastric mucosa, jejunum and sigmoid colon. Morphologically, it was expressed in chronic inflammation without acute manifestations.

    Topics: Drug Combinations; Humans; Intestinal Diseases; Intestinal Mucosa; Pectins; Peritonitis; Probiotics; Syndrome; Technology, Pharmaceutical

2012
[Experimental and clinical evaluation of a modified pectin-containing drugs in the treatment of intestinal insufficiency in peritonitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2009, Issue:2

    Experimental studies on 26 rats showed a stimulating effect of beet pectin at small intestine with paresis, mucosal repair, and bactericidal action on intestinal microflora. In comparison of activity intensity of small intestine solder at 1 day was 2.5-1.75 times less than 3 days and it is not reached. In the experimental group at 1 day solder activity was lower than the norm for the divisions in the 1.7-1.64--1.53-fold, and by 3 days, respectively, exceeded the norm of 0.8-2.4--2.25 times. We examined 150 patients aged 19 to 86 years with poured peritonitis primarily toxic (85.3%). III. The main causes of peritonitis were acute appendicitis (24.0%) and perforation of gastroduodenal ulcers (21.3%). For a comparative analysis of results of treatment were formed 3 patient groups using paired sample. Control group patients received conventional treatment. Enterosorption conducted through nazointestinalny probe known carbon sorbent UAO-A and pektincontents products (SAPs) the dining beet sublimate materials. The results are compared. Reducing the time used to resolve paresis of intestine and nazointestinal intubation in 1,3 times, reducing the severity of the patient on a scale of SAPS is already at 2 hours improving immunity more rapid decline in toxicity of blood plasma and leukocyte index of intoxication, reduction of postoperative pneumonia in 12% and postoperative mortality from 14% to 6.6% showed the advantages enterosorption modified pectin contents drug.

    Topics: Adult; Aged; Aged, 80 and over; Animals; Beta vulgaris; Enterosorption; Gastrointestinal Motility; Humans; Intestine, Small; Intubation, Gastrointestinal; Microbial Sensitivity Tests; Middle Aged; Pectins; Peritonitis; Severity of Illness Index; Treatment Outcome; Young Adult

2009
[Early postoperative enteral immunocorrection using modified pectin containing drugs in peritonitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2009, Issue:6

    Surgical endotoxicosis entails dysfunction of all organs and systems including immune system that considerably aggravates severity of current disease and slows down a recovery in the postoperative period. Searching of various ways of immunocorrection in peritonitis of various etiology is the actual commitment of the contemporary surgery. The complex method of simultaneous enterosorbtion and immunocorrection with the modified pectin contained specimen in patients with a peritonitis is offered. In study the role natural enteral sorbents in optimization of the immune answer due to restoration of microbiocenosis sorbtion and immunocorrection modified with the modified pectin contained intestines is proved. Entero specimen provide decreasing of medium molecular weight substances' level to 89.0% in reactive stage of a peritonitis and to 69.0%--in toxic stage during 3 days. By 5th day of treatment the level of medium molecular weight substances and leucocyte intoxication index were already reached to the normal parameters. It allows us to recommend this introducted method in a complex of medical treatment in postoperation period in peritonitis.

    Topics: Animals; Antidiarrheals; Enteral Nutrition; Enterosorption; Humans; Male; Pectins; Peritonitis; Postoperative Care; Rats; Rats, Wistar; Time Factors

2009
[Enterosorption and nutritious support with pectin-containing preparation in the treatment of stress immunodeficiency in peritonitis].
    Khirurgiia, 2005, Issue:7

    Fifty-eight patients aged from 18 to 65 years with peritonitis of different etiology in toxic and terminal phases were treated. Nasoenteral intubation, enterosorption and early nutritious support with pectin-containing preparation (PCP) were carried out in all the patients just after surgery with standard course of 5 days. Baseline data was compared with that after PCP-supported treatment. Powder products of red beet were used as PCP. Immunodeficiency in peritonitis is characterized by imbalance of stress-realizing and stress-limiting mechanisms of immunocompetent cells. Enterosorption and early nutritious support with PCP in peritonitis decrease the level of plasmic cortisol and enhance stress-limiting reception that reduces a harmful effect of cortisol and reestablishes immunity.

    Topics: Adolescent; Adult; Aged; Antidiarrheals; B-Lymphocytes; CD4-CD8 Ratio; Enterosorption; Follow-Up Studies; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Intubation, Gastrointestinal; Middle Aged; Nutritional Support; Pectins; Peritonitis; Stress, Physiological; T-Lymphocytes; Treatment Outcome

2005